Serum Vascular Endothelial Growth Factor and Insulin-Like Growth Factor-1 in Liver Cirrhosis: Relation to Disease Severity and Development of Portal Hypertension

ASSESSMENT OF ENDOTHELIAL FUNCTION IN PATIENTS WITH PORTAL HYPERTENSION

Impact of vascular endothelial growth factor on prognosis of patients with hepatocellular carcinoma treated with angiotensin-converting-enzyme inhibitors

The Relationship of Angiotensin I-Converting Enzyme Genotype to Liver Fibrogenesis in Non-Alcoholic Steatohepatitis

Study of Plasma Cyclic Guanosine Monophosphate as a New Marker in Patients with Portal Hypertension

EFFECT OF SPLENECTOMY ON LIVER FIBROGENICITY IN PORTAL HYPERTENSION PATIENTS

Perinodopril, an angiotensin converting enzyme inhibitor, attenuates experimental hepatic fibrosis

EFFECT OF HCV DIRECT ANTIVIRAL AGENTS ON PORTAL CIRCULATION HEMODYNAMICS IN CIRRHOTIC PATIENTS

PORTAL HYPERTENSION TREATMENT WITH CANDESARTAN PLUS PROPRANOLOL FOR NINE MONTHS RESTORES NORMAL PORTAL CIRCULATION HEMODYNAMIC PATTERN

Angiotensin-Converting Enzyme Inhibitor “Lisinopril” Antagonizes Hepatic TGF-β1, improving Hepatic Fibrosis Caused by Experimental Schistosomiasis mansoni